Clinical Trials Browser

Phase 2 × Completed × icotinib × Clear all

NCT05263947 2026-02-24

Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02264210 2024-09-25

CORIN

Phase 2 Completed

128 enrolled 9 charts

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02044328 2022-02-08

ICAPE

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02934256 2021-09-09

Icotinib

Phase 2 Completed

Neuroma, Acoustic, Neurofibromatosis 2

NCT03736837 2021-03-15

ALTER-L004

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01855854 2019-07-05

Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Phase 2 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis